tradingkey.logo

Cencora Inc

COR
View Detailed Chart

293.985USD

-8.535-2.82%
Market hours ETQuotes delayed by 15 min
56.99BMarket Cap
30.04P/E TTM

Cencora Inc

293.985

-8.535-2.82%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.82%

5 Days

+0.51%

1 Month

-0.30%

6 Months

+13.92%

Year to Date

+30.85%

1 Year

+22.56%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
2 / 207
Overall Ranking
45 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 18 analysts
Buy
Current Rating
331.461
Target Price
+9.57%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 293.96B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.21% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 27.58%.
Fairly Valued
The company’s latest PE is 30.81, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 191.45M shares, decreasing 0.10% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 22.40M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Ticker SymbolCOR
CompanyCencora Inc
CEODr. Robert P. (Bob) Mauch, Ph.D.
Websitehttps://www.cencora.com/
KeyAI